Comment from George Washington University

Summary: Dr. James A. Simon, a clinical professor at George Washington University, argues against the FDA's decision to deny an ANDA for ESTRATEST® Brand Tablets. He contends that the FDA has reached inaccurate conclusions regarding the patient population for estrogen-androgen combination therapy and emphasizes the clinical necessity of these drugs for women who do not achieve symptom relief with estrogen alone.